| Literature DB >> 29250341 |
David E Hartigan1, Itay Perets2, Leslie C Yuen2, Benjamin G Domb2,3.
Abstract
The aim of this article is to examine the results of arthroscopic management of patients with labral pathology who have preoperative magnetic resonance images (MRIs) demonstrating subchondral cysts. This institution's database was searched for patients who underwent hip arthroscopy and had subchondral cysts on MRI and >2-year follow-up. Exclusion criteria included previous hip surgery, Tönnis grade >1, inflammatory arthritis, Perthes, slipped capital femoral epiphysis or abductor repair. Patient-reported outcome (PRO) scores including visual analog scale, modified Harris hip score (mHHS), non-arthritic hip score and hip outcome score sports-specific subscale (HOS-SSS) were gathered preoperatively, at 3 months, and annually thereafter. The change in PRO scores was compared with the minimally clinical important difference (MCID) to quantify improvement. Sixty-nine patients were eligible for this study, of which 65 (94%) had >2-year follow-up. All PROs were significantly improved at latest follow-up (P < 0.001). Mean patient satisfaction was 7.2. There was no correlation between Outerbridge grade III or IV cartilage damage noted during arthroscopy and subchondral femoral and acetabular cysts noted on MRI. Seventeen patients required reoperation [13 total hip arthroplasty (THAs) and 4 revision arthroscopies]. Patients with femoral subchondral cysts converted to THA 36% of the time. MCIDs for mHHS and HOS-SSS were surpassed by 63% and 68% of patients, respectively. Hip arthroscopies performed on patients with subchondral cysts present on preoperative MRI should be approached with caution. The rate of conversion to hip arthroplasty appears to be higher than that reported in the literature for patients who undergo arthroscopy without preoperative subchondral cysts. For patients who did not require hip arthroplasty or revision arthroscopy, patients demonstrated significant improvement in symptoms compared with the preoperative state.Entities:
Year: 2017 PMID: 29250341 PMCID: PMC5721372 DOI: 10.1093/jhps/hnx034
Source DB: PubMed Journal: J Hip Preserv Surg ISSN: 2054-8397
Demographics and results of patients within this study’s cohort
| Demographics | ||
|---|---|---|
| Total eligible | 69 | |
| F/U (>2 years) | 65 | 94.2% |
| F/U time (months) | 42 (23.1–89.7) | |
| Gender | ||
| Male | 41 | 63.1% |
| Female | 24 | 36.9% |
| Surgical side | ||
| Right | 45 | 69.2% |
| Left | 20 | 30.8% |
| BMI | 27.1 (13.5–43.4) | |
| Age | 43.6 (16.8–63.9) | |
| Patient satisfaction | 7.23 (0–10) | |
| Future revision | 4 | 6.2% |
| Time to revision (months) | 30.4 (19.2–49.7) | |
| Conversion to THA | 13 | 20.0% |
| Time to THA (months) | 23.6 (3.5–59.7) | |
| Subchondral cyst type | ||
| Acetabular | 53 | 81.5% |
| Femoral | 11 | 16.9% |
| Both | 1 | 1.5% |
THA, total hip arthroplasty; f/u, follow-up; BMI, body mass index.
Procedures carried out at the time of arthroscopy
| Procedures | % | |
|---|---|---|
| Acetabuloplasty | 43 | 66.2 |
| Femoroplasty | 55 | 84.6 |
| Labral treatment | ||
| Simple repair | 25 | 38.5 |
| Base repair | 9 | 13.8 |
| Debridement | 31 | 47.7 |
| Capsular treatment | ||
| Repair/plication | 14 | 21.5 |
| Release | 51 | 78.5 |
| Notchplasty | 10 | 15.4 |
| Microfracture | ||
| Femoral | 0 | 0.0 |
| Acetabular | 15 | 23.1 |
| Ligamentum teres treatment | 36 | 55.4 |
| Iliopsoas release | 13 | 20.0 |
| Iliopsoas bursectomy | 1 | 1.5 |
| Trochanteric bursectomy | 2 | 3.1 |
| Removal of loose body | 12 | 18.5 |
Fig. 1.Demonstrates the change from the preoperative to the postoperative setting with visual analog scale rating of pain (VAS).
Fig. 2.Demonstrates the change in the various patient reported outcomes from preoperative setting (blue) to the postoperative setting (red). mHHS, modified Harris hip score; NAHS, non-arthritic hip score; HOS-SSS, hip outcome scores-sports specific subscale.
Various demographic variables for patients with femoral and acetabular cysts
| Demographics | Acetabular | femoral head | Both | |
|---|---|---|---|---|
| Total eligible | 57 | 11 | 1 | |
| F/U (>2 years) | 53 | 11 | 1 | |
| F/U time (months) | 39.7 (4.8–89.7) | 31.3 (3.0–75.8) | 3.9 | |
| Gender | ||||
| Male | 34 | 6 | 0.7336 | 1 |
| Female | 19 | 5 | 0 | |
| Surgical side | ||||
| Right | 40 | 5 | 1 | |
| Left | 13 | 6 | 0 | |
| BMI | 27.2 (13.5–43.4) | 27.1 (19.2–35.6) | 0.809 | 30.4 |
| Age | 43.5 (16.8–61.3) | 43.4 (19.0–63.9) | 0.7 | 56.9 |
| Future revision | 3 | 1 | 0 | |
| Time to revision (months) | 32.9 (19.2–49.7) | 22.9 | ||
| Conversion to THA | 9 | 4 | 0 | |
| Time to THA (months) | 26.6 (3.5–59.3) | 15.7 (9.9–20.9) | ||
| Patient satisfaction (0–10) | 7.2 (0–10) | 7.6 (0–10) | 8 | |
| Patient reported outcome scores | ||||
| Δ mHHS | 11.1 (±23.6) | 13.4 (±22.9) | 0.81 | 15.8 |
| Δ NAHS | 19.8 (±19.6) | 11.1 (±17.5) | 0.27 | 21.25 |
| Δ HOS-SSS | 21.3 (±30.1) | 20.6 (±46.9) | 0.96 | 55.5 |
| Δ VAS | −2.6 (±3.2) | −1.4 (±3.4) | 0.37 | 0 |
F/u, follow-up; BMI, body mass index; THA, total hip arthroplasty; mHHS, modified harris hip score; NAHS, non-arthritic hip score; HOS-SSS, hip outcome score-sports specific subscale; VAS, visual analog score.
Number of total hips done on patients with acetabular and femoral cysts
| Number total hips | ||
|---|---|---|
| Acetabular cysts | 9 (15.5%) | 0.14 |
| Femoral head cysts | 4 (33.3%) |
Number of patients that exceeded the MCID for acetabular and femoral cyst groups
| MCID | Acetabular cyst | Femoral head cyst | |
|---|---|---|---|
| mHHS | 30 (61.2%) | 6 (75%) | 0.45 |
| HOS-SSS | 35 (71.4%) | 4 (50%) | 0.22 |
Correlation between Outerbridge grade III/IV cartilage damage on diagnostic arthroscopy and subchondral cysts presence in that same location
| High Outerbridge grade (3,4) | Phi | ||
|---|---|---|---|
| Acetabular Outerbridge | 0.123 | 0.2804 | |
| Acetabular cyst | 38 (58.5%) | ||
| No acetabular cyst | 9 (52.5%) | ||
| Femoral Outerbridge | 0.0611 | 0.594 | |
| Fermoral head cyst | 2 (18.1%) | ||
| No femoral head cyst | 8 (12.3%) |